Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New PKC inhibitors in development at AstraZeneca

Oct. 14, 1999

Preclinical, early clinical results indicate good efficacy and safety of D-4418

Oct. 13, 1999

Glaxo Wellcome receives approval in Germany for Flixotide in COPD

Oct. 13, 1999

News from ERS: tiotropium prevents methacholine-induced bronchoconstriction in asthmatics

Oct. 13, 1999

PDE3 inhibitor olprinone is an effective bronchodilator in asthma patients

Oct. 13, 1999

DHA: a new treatment for CF on the horizon?

Oct. 13, 1999

Positive phase I/II reported for Nuvance at European meeting

Oct. 13, 1999

Sheffield and Elan establish licensing agreement to develop respiratory products

Oct. 12, 1999

Sch-55700 prevents a variety of eosinophilic responses in animal models

Oct. 7, 1999

PKC, cytokine inhibitors in development at AstraZeneca

Oct. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...